Systolic blood pressure · people with acute stroke
1 finding from 1 review
Diastolic blood pressure · people with acute stroke
1 finding from 1 review
Heart rate · people with acute stroke
1 finding from 1 review
Adverse effects: headache · people with acute stroke
Glyceryl trinitrate (GTN) leads to higher adverse event: Headache, on treatment (7‐12 days) compared with no GTN (high certainty).
1 finding from 1 review
Intervention not reported
Death or dependency at end of scheduled · people with stroke
The intervention probably leads to lower death or dependency at end of scheduled (moderate certainty).
1 finding from 1 review
Intervention not reported
Death at end of scheduled · people with stroke
The intervention showed no clear difference in death at end of scheduled (moderate certainty).
1 finding from 1 review
Intervention not reported
Death or institution care at end of scheduled · people with stroke
The intervention probably leads to lower death or institution care at end of scheduled (moderate certainty).
1 finding from 1 review
Intervention not reported
Extended activities of daily living (EADL) score at end of scheduled · people with stroke
The intervention may leads to higher extended activities of daily living (EADL) score at end of scheduled (low certainty).
1 finding from 1 review
Intervention not reported
Satisfaction with services at end of scheduled · people with stroke
The intervention may leads to higher satisfaction with services at end of scheduled (low certainty).
1 finding from 1 review
Intervention not reported
Length of initial hospital stay (days) · people with stroke
The intervention probably leads to higher length of initial hospital stay (days) (moderate certainty).
1 finding from 1 review
Intervention not reported
Readmission to hospital at end of scheduled · people with stroke
The intervention showed no clear difference in readmission to hospital at end of scheduled (low certainty).
1 finding from 1 review
Dysarthria intervention versus any control for stroke subgroup: persisting effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
2 findings from 1 review
Dysarthria intervention versus any control: persisting effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Participation · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, activity level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dysarthria intervention versus any control: immediate effects, impairment level · adults with dysarthria following stroke or other adult‐acquired, non‐progressive brain injury
1 finding from 1 review
Dropouts ‐ by end of treatment Numbers of dropouts and adverse events · adults who had suffered a stroke and exhibited an abnormal gait pattern
1 finding from 1 review
Walking speed (m/s) at end of treatment timed measures of gait · adults who had suffered a stroke and exhibited an abnormal gait pattern
1 finding from 1 review
Activity Gait speed · adults who had suffered a stroke and exhibited an abnormal gait pattern
2 findings from 1 review
Walking endurance · adults who had suffered a stroke and exhibited an abnormal gait pattern
1 finding from 1 review